Advisory Committee on Heritable Disorders in Newborns and Children, 2554-2555 [2010-671]

Download as PDF 2554 Federal Register / Vol. 75, No. 10 / Friday, January 15, 2010 / Notices jlentini on DSKJ8SOYB1PROD with NOTICES medicine; unmet needs in diagnostic testing for women with cardiovascular disease; issues of cardiovascular prevention across the lifespan with an emphasis on gender and underserved populations; and women’s careers in the biomedical sciences. On February 17, the morning session will be devoted to reports by the working group co-chairs regarding the recommendations emerging from working group deliberations on the previous day. The meeting will adjourn at 12:15 p.m. on February 17. Public Testimony ORWH invites individuals with an interest in research related to women’s health to provide written and/or oral testimony on these topics and/or on issues related to the sustained advancement of women in various biomedical careers. Due to time constraints, only one representative from an organization or professional specialty group may submit oral testimony. Individuals not representing an organized entity but a personal point of view are similarly invited to present written and/or oral testimony. A letter of intent to present oral testimony is necessary and should be sent electronically to https:// www.orwhmeetings.com/ movingintothefuture/Emory or by mail to Ms. Jory Barone, Educational Services, Inc., 4350 East West Highway, Suite 1100, Bethesda, MD 20814, no later than midnight February 1, 2010. The date of receipt of the communication will establish the order of those selected to give oral testimony at the February meeting. Those wishing to present oral testimony are also asked to submit a written form of their testimony that is limited to a maximum of 10 pages, double spaced, 12-point font, and should include a brief description of the organization. Electronic submission to the above Web site is preferred; however, for those who do not have access to electronic means, written testimony, bound by the restrictions previously noted and postmarked no later than February 1, 2010, can be mailed to Ms. Jory Barone at the above address. All written presentations must meet the established page limitations. Submissions exceeding this limit will not be accepted and will be returned. Oral testimony of this material at the meeting will be limited to no more than 5–6 minutes in length. Because of time constraints for oral testimony, testifiers may not be able to present the complete information as it is contained in their written form submitted for inclusion in the public VerDate Nov<24>2008 17:34 Jan 14, 2010 Jkt 220001 record for the meeting. Therefore, testifiers are requested to summarize the major points of emphasis from the written testimony not to exceed 6 minutes of oral testimony. Those individuals and/or organizations who have indicated that they will present oral testimony at the meeting in Atlanta, will be notified prior to the meeting regarding the approximate time for their oral presentation. Individuals and organizations wishing to provide written statements only should send a copy of their statements, electronically or by mail, to the above Web site or address by February 1, 2010. Written testimony received by that date will be made available at the February 16–17 meeting. Logistics questions related to the meeting should be addressed to Ms. Jory Barone, joryb@esi-dc.com at ESI, while program-specific questions should be addressed to Dr. Nanette K. Wenger at the Emory University School of Medicine, Atlanta, 404–616–4420, nwenger@emory.edu. The resulting report to the ORWH and the NIH will ensure that women’s health research in the coming decade continues to support a vigorous research agenda incorporating the latest advances in technology and cutting edge science in support of women’s cardiovascular health. Dated: January 8, 2010. Francis S. Collins, Director, National Institutes of Health. [FR Doc. 2010–665 Filed 1–14–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Heritable Disorders in Newborns and Children AGENCY: Health Resources and Services Administration (HRSA), HHS. ACTION: Notice of Request for Nominations. SUMMARY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill three (3) vacancies on the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Authority: Section 1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b–10, as amended in the Newborn Screening Saves Lives Act of 2008 (Act). The Committee is governed by the provisions of Public Law 92– 463, as amended (5 U.S.C. App. 2), and 41 CFR Part 102–3, which sets forth standards PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 for the formation and use of advisory committees. DATES: The agency must receive nominations on or before May 1, 2010. ADDRESSES: All nominations are to be submitted to Michele A. Lloyd-Puryear, M.D., PhD, Designated Federal Official and Executive Secretary, Advisory Committee on Heritable Disorders in Newborns and Children, and Chief, Genetic Services Branch, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. E-mailed nominations can be sent to Screening@hrsa.hhs.gov. FOR FURTHER INFORMATION CONTACT: Ms. Alaina Harris, Genetic Services Branch, Maternal and Child Health Bureau, HRSA, at aharris@hrsa.gov or (301) 443–1080. A copy of the Committee Charter and list of the current membership can be obtained by contacting Ms. Harris or by accessing the Advisory Committee Web site at https://hrsa.gov/ heritabledisorderscommittee. SUPPLEMENTARY INFORMATION: The Secretary’s ACHDNC is chartered under section 1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b–10, as amended by the Newborn Screening Saves Lives Act 2008 (Act). The Committee was established in February 2003 to advise the Secretary of the U.S. Department of Health and Human Services. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App. 2), and 41 CFR Part 102–3, which sets forth standards for the formation and use of advisory committees. The ACHDNC is directed to review and report regularly on newborn and childhood screening practices for heritable disorders and to recommend improvements in the national newborn and childhood heritable screening programs. The Committee is established to advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. In addition, the Committee provides advice and recommendations to the Secretary concerning the grants and projects authorized under section 1109 and technical information to develop policies and priorities for this Program that will enhance the ability of the State and local health agencies to provide for newborn and child screening, counseling and health care services for E:\FR\FM\15JAN1.SGM 15JAN1 jlentini on DSKJ8SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 10 / Friday, January 15, 2010 / Notices newborns and children having or at risk for heritable disorders. Specifically, HRSA is requesting nominations for three (3) voting members to serve on the Committee. Members shall be selected from medical, technical, public health or scientific professionals with special expertise in the field of heritable disorders or in providing screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders and from members of the public having special expertise about or concern with heritable disorders. The individuals selected for appointment to the Committee can be invited to serve for overlapping terms of up to 4 years. However, any member appointed to fill a vacancy of an unexpired term shall be appointed for the remainder of such term. Members may serve after the expiration of their term until their successors have taken office. Terms of more than 2 years are contingent upon the renewal of the Committee by appropriate action prior to its expiration. Members who are not Federal employees will receive a stipend for each day they are engaged in the performance of their duties as members of the Committee. Members shall receive per diem and travel expenses as authorized by section 5 U.S.C. 5703 for persons employed intermittently in Government service. Members who are officers or employees of the United States Government shall not receive compensation for service on the Committee. Nominees will be invited to serve beginning from October 1, 2010. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee and appears to have no conflict of interest that would preclude the Committee membership—potential candidates will be asked to provide detailed information concerning consultancies, research grants, or contracts to permit evaluation of possible sources of conflicts of interest; (2) the nominator’s name, address, and daytime telephone number, and the home/or work address, telephone number, and e-mail address of the individual being nominated; and (3) a current copy of the nominee’s VerDate Nov<24>2008 17:34 Jan 14, 2010 Jkt 220001 curriculum vitae. Please submit nominations no later than May 1, 2010. To the extent practicable, members of the Committee should have expertise in dealing with heritable disorders and genetic diseases that affect the racial and ethnic and geographical diversity of newborns served by the State newborn screening programs. The Department of Health and Human Services will ensure that the membership of the Committee reflects an equitable geographical and gender distribution, provided that the effectiveness of the Committee would not be impaired. Appointments shall be made without discrimination on the basis of age, ethnicity, gender, sexual orientation, and cultural, religious, or socioeconomic status. Dated: January 11, 2010. Mary K. Wakefield, Administrator. [FR Doc. 2010–671 Filed 1–14–10; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2009–0158] Homeland Security Science and Technology Advisory Committee Science and Technology Directorate, DHS. ACTION: Committee management; Notice of closed Federal Advisory Committee meeting. AGENCY: SUMMARY: The Homeland Security Science and Technology Advisory Committee will meet January 26–28, 2010, at the Department of Homeland Security, 1120 Vermont Ave., NW., Washington, DC. This meeting will be closed to the public. DATES: The Homeland Security Science and Technology Advisory Committee will meet January 26, 2010, from 9 a.m. to 5 p.m., January 27, 2010, from 9 a.m. to 5 p.m. and on January 28, 2010, from 8 a.m. to 11 a.m. ADDRESSES: The meeting will be held at the Department of Homeland Security, 1120 Vermont Ave., NW., Washington, DC. Requests to have written material distributed to each member of the committee prior to the meeting should reach the contact person at the address below by Friday, January 8, 2010. Send written material to Ms. Tiwanda Burse, Science and Technology Directorate, Department of Homeland Security, 245 Murray Lane, Bldg. 410, Washington, DC 20528. Comments must be identified by DHS–2009–0158 and may be submitted by one of the following methods: PO 00000 Frm 00081 Fmt 4703 Sfmt 9990 2555 • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • E-mail: HSSTAC@dhs.gov. Include the docket number in the subject line of the message. • Fax: 202–254–6173. • Mail: Ms. Tiwanda Burse, Science and Technology Directorate, Department of Homeland Security, 245 Murray Lane, Bldg. 410, Washington, DC 20528. Instructions: All submissions received must include the words ‘‘Department of Homeland Security’’ and the docket number for this action. Comments received will be posted without alteration at https://www.regulations.gov, including any personal information provided. Docket: For access to the docket to read background documents or comments received by the (committee name), go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Ms. Tiwanda Burse, Science and Technology Directorate, Department of Homeland Security, 245 Murray Lane, Bldg. 410, Washington, DC 20528, 202– 254–6877. Notice of this meeting is given under the Federal Advisory Committee Act, 5 U.S.C. App. (Pub. L. 92–463). At this meeting, the Committee will receive sensitive and classified (Top Secret-level) briefings and presentations regarding relationships between Science & Technology and selected Defense related topics concerning matters sensitive to homeland security. Basis for Closure: In accordance with Section 10(d) of the Federal Advisory Committee Act, it has been determined that the Homeland Security Science and Technology Advisory Committee meeting concerns sensitive Homeland Security information and classified matters within the meaning of 5 U.S.C. 552b(c)(1) and (c)(9)(B) which, if prematurely disclosed, would significantly jeopardize national security and frustrate implementation of proposed agency actions and that, accordingly, the portion of the meeting that concerns these issues will be closed to the public. SUPPLEMENTARY INFORMATION: Dated: January 7, 2010. Tara O’Toole, Under Secretary for Science and Technology. [FR Doc. 2010–737 Filed 1–14–10; 8:45 am] BILLING CODE 9910–9F–P E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 75, Number 10 (Friday, January 15, 2010)]
[Notices]
[Pages 2554-2555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders in Newborns and 
Children

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice of Request for Nominations.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill three (3) vacancies on the Secretary's 
Advisory Committee on Heritable Disorders in Newborns and Children.

    Authority: Section 1111 of the Public Health Service (PHS) Act, 
42 U.S.C. 300b-10, as amended in the Newborn Screening Saves Lives 
Act of 2008 (Act). The Committee is governed by the provisions of 
Public Law 92-463, as amended (5 U.S.C. App. 2), and 41 CFR Part 
102-3, which sets forth standards for the formation and use of 
advisory committees.

DATES: The agency must receive nominations on or before May 1, 2010.

ADDRESSES: All nominations are to be submitted to Michele A. Lloyd-
Puryear, M.D., PhD, Designated Federal Official and Executive 
Secretary, Advisory Committee on Heritable Disorders in Newborns and 
Children, and Chief, Genetic Services Branch, Maternal and Child Health 
Bureau, Health Resources and Services Administration, Room 18A-19, 
Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. E-
mailed nominations can be sent to Screening@hrsa.hhs.gov.

FOR FURTHER INFORMATION CONTACT: Ms. Alaina Harris, Genetic Services 
Branch, Maternal and Child Health Bureau, HRSA, at aharris@hrsa.gov or 
(301) 443-1080. A copy of the Committee Charter and list of the current 
membership can be obtained by contacting Ms. Harris or by accessing the 
Advisory Committee Web site at https://hrsa.gov/heritabledisorderscommittee.

SUPPLEMENTARY INFORMATION: The Secretary's ACHDNC is chartered under 
section 1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b-10, 
as amended by the Newborn Screening Saves Lives Act 2008 (Act). The 
Committee was established in February 2003 to advise the Secretary of 
the U.S. Department of Health and Human Services. The Committee is 
governed by the provisions of Public Law 92-463, as amended (5 U.S.C. 
App. 2), and 41 CFR Part 102-3, which sets forth standards for the 
formation and use of advisory committees. The ACHDNC is directed to 
review and report regularly on newborn and childhood screening 
practices for heritable disorders and to recommend improvements in the 
national newborn and childhood heritable screening programs.
    The Committee is established to advise and guide the Secretary 
regarding the most appropriate application of universal newborn 
screening tests, technologies, policies, guidelines and programs for 
effectively reducing morbidity and mortality in newborns and children 
having or at risk for heritable disorders. In addition, the Committee 
provides advice and recommendations to the Secretary concerning the 
grants and projects authorized under section 1109 and technical 
information to develop policies and priorities for this Program that 
will enhance the ability of the State and local health agencies to 
provide for newborn and child screening, counseling and health care 
services for

[[Page 2555]]

newborns and children having or at risk for heritable disorders.
    Specifically, HRSA is requesting nominations for three (3) voting 
members to serve on the Committee. Members shall be selected from 
medical, technical, public health or scientific professionals with 
special expertise in the field of heritable disorders or in providing 
screening, counseling, testing or specialty services for newborns and 
children at risk for heritable disorders and from members of the public 
having special expertise about or concern with heritable disorders.
    The individuals selected for appointment to the Committee can be 
invited to serve for overlapping terms of up to 4 years. However, any 
member appointed to fill a vacancy of an unexpired term shall be 
appointed for the remainder of such term. Members may serve after the 
expiration of their term until their successors have taken office. 
Terms of more than 2 years are contingent upon the renewal of the 
Committee by appropriate action prior to its expiration. Members who 
are not Federal employees will receive a stipend for each day they are 
engaged in the performance of their duties as members of the Committee. 
Members shall receive per diem and travel expenses as authorized by 
section 5 U.S.C. 5703 for persons employed intermittently in Government 
service. Members who are officers or employees of the United States 
Government shall not receive compensation for service on the Committee. 
Nominees will be invited to serve beginning from October 1, 2010.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee and appears to have no conflict 
of interest that would preclude the Committee membership--potential 
candidates will be asked to provide detailed information concerning 
consultancies, research grants, or contracts to permit evaluation of 
possible sources of conflicts of interest; (2) the nominator's name, 
address, and daytime telephone number, and the home/or work address, 
telephone number, and e-mail address of the individual being nominated; 
and (3) a current copy of the nominee's curriculum vitae. Please submit 
nominations no later than May 1, 2010.
    To the extent practicable, members of the Committee should have 
expertise in dealing with heritable disorders and genetic diseases that 
affect the racial and ethnic and geographical diversity of newborns 
served by the State newborn screening programs. The Department of 
Health and Human Services will ensure that the membership of the 
Committee reflects an equitable geographical and gender distribution, 
provided that the effectiveness of the Committee would not be impaired. 
Appointments shall be made without discrimination on the basis of age, 
ethnicity, gender, sexual orientation, and cultural, religious, or 
socioeconomic status.

    Dated: January 11, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010-671 Filed 1-14-10; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.